Sorrento Therapeutics Inc (SRNE): I think Sorrento's ABIVERTINIB $61 B...

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Followers	57
Posts	5700
Boards Moderated	0
Alias Born	12/13/2004

dia76ca

Re: None

Tuesday, 01/04/2022 6:52:25 PM

Tuesday, January 04, 2022 6:52:25 PM

I think Sorrento's ABIVERTINIB $61 Billion market potential "teaser" would draw some Big Pharma interest! But any BP doing their dd on ABIVERTINIB would surely look at the entire Sorrento portfolio while they were at it. They could not miss the near term multi-billion SEMDEXA revenue stream...the world's largest anti-covid program...the blockbuster ADNAB,DAR-T, CAR-T, ADC and oncolytic virus programs!
This reminds me of the 2009 $47 Billion Roche acquisition of Genentech. This was two stage. First a very large partnership followed by the buy-out. It has paid off for Roche.
https://dashboards.trefis.com/no-login-required/gQPFxQfz?fromforbesandarticle=was-the-47-billion-acquisition-of-genentech-in-2009-a-good-deal-for-roche
I would not bet against a very similar partnership/buyout or just simple buyout occurring for Sorrento in 2022!

"The refusal of the real is the number one dogma of our time" Rene Girard

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent SRNE News

Form 8-K - Current report • Edgar (US Regulatory) • 11/03/2023 09:31:06 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/27/2023 08:15:31 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/13/2023 01:51:06 AM
Form 8-K - Current report • Edgar (US Regulatory) • 08/28/2023 09:25:07 PM
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/07/2023 08:15:35 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/01/2023 10:01:54 AM
Form 8-K - Current report • Edgar (US Regulatory) • 07/13/2023 10:26:26 AM